Поисковый запрос: (<.>A=Sehested, Maxwell$<.>) |
Общее количество найденных документов : 27
Показаны документы с 1 по 20
|
|
1.
| US-guided fine needle biopsy of solid renal masses: Comparison of histology and cytology // Scand. J. Urol. and Nephrol., 1991, Suppl. 137.-С.41-43
|
2.
| US-guided fine needle biopsy of solid renal masses: Comparison of histology and cytology // Scand. J. Urol. and Nephrol., 1991, Suppl. 137.-С.41-43
|
3.
| Treatment of experimental extravasation of amrubicin, liposomal doxorubicin, and mitoxantrone with dexrazoxane // Cancer Chemother. and Pharmacol., 2012. Vol. 69, N 2.-С.573-576
|
4.
| Targeting the cytotoxicity of topoisomerase II-directed epipodophyllotoxins to tumor cells in acidic environments // Cancer Res., 1994. Vol. 54, N 11.-С.2959-2963
|
5.
| Sorensen pH-dependent regulation of campothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine // Biochem. Pharmacol., 1997. Vol. 54, N 3.-С.373-380
|
6.
| Sorensen pH-dependent regulation of campothecin-induced cytotoxicity and cleavable complex formation by the antimalarial agent chloroquine // Biochem. Pharmacol., 1997. Vol. 54, N 3.-С.373-380
|
7.
| Sehested The carboxylic ionophore monensin inhibits active drug efflux and modulates in vitro resistance in daunorubicin resistant Ehrlich ascites tumor cells // Biochem. Pharmacol., 1988. Vol. 37, N 17.-С.3305-3310
|
8.
| Relationship of VP-16 to the classical multidrug resistance phenotype // Cancer Res., 1992. Vol. 52, N 10.-С.2874- 2879
|
9.
| Langer Seppo W. Treatment of anthracycline extravasation with dexrazoxane // Clin. Cancer Res., 2000. Vol. 6, N 9.-С.3680-3686
|
10.
| Langer Seppo W. Treatment of anthracycline extravasation with dexrazoxane // Clin. Cancer Res., 2000. Vol. 6, N 9.-С.3680-3686
|
11.
| Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907
|
12.
| Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907
|
13.
| Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907
|
14.
| Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity // Clin. Cancer Res., 1999. Vol. 5, N 10.-С.2899-2907
|
15.
| Freeze-fracture study of plasma membranes in wild type and daunorubicin-resistant Ehrlich ascites tumor and P388 leukemia cells // Virchows Arch. B, 1989. Vol. 56, N 5.-С.327-335
|
16.
| Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy // Toxicology, 2009. Vol. 255, N 1-2.-С.72-79
|
17.
| Essential mitotic fuctions of DNA topoisomerase II'альфа' are not adopted by topoisomerase II'бета' in human H69 cells // J. Biol. Chem., 1998. Vol. 273, N 50.-С.33660-33666
|
18.
| E2F-1-Induced p53-independent apoptosis in transgenic mice // Oncogene, 1998. Vol. 17, N 2.-С.143-155
|
19.
| Demant Erland J.F. Characterization of the cooperative cross-linking of doxorubicin N-hydroxysuccinimide ester derivatives to water soluble proteins // Biochim. et biophys. acta. Protein Struct. and Mol. Enzymol., 1991. Vol. 1118, N 1.-С.83-90
|
20.
| Demant Erland J.F. A model for computer simulation of P-glycoprotein and transmembrane 'ДЕЛЬТА'pH-mediated anthracycline transport in multidrug-resistant tumor cells // Biochim. et biophys. acta. Mol. Cell. Res., 1990. Vol. 1055, N 2.-С.117-125
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"